Journal article
Should methotrexate have any place in the treatment of psoriatic arthritis?
- Abstract:
- Methotrexate (MTX) is widely used in the treatment of psoriatic arthritis (PsA) despite the evidence base for this being limited. This narrative review summarises the evidence to date of using MTX within different domains of psoriatic disease, including peripheral arthritis, axial disease, dactylitis, enthesitis, psoriasis and nail disease. We also explore the role of MTX in combination therapy with tumour necrosis factor inhibitors, in addition to its safety and tolerability, to answer the question: should methotrexate have any place in the treatment of psoriatic arthritis?
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 191.2KB, Terms of use)
-
- Publisher copy:
- 10.1016/j.rdc.2019.04.007
Authors
+ National Institute for Health Research
More from this funder
- Funding agency for:
- Coates, L
- Grant:
- Clinician Scientist award
- Publisher:
- Elsevier
- Journal:
- Rheumatic Disease Clinics of North America More from this journal
- Volume:
- 45
- Issue:
- 3
- Pages:
- 325-339
- Publication date:
- 2019-05-30
- Acceptance date:
- 2019-04-24
- DOI:
- EISSN:
-
1558-3163
- ISSN:
-
0889-857X
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:1022723
- UUID:
-
uuid:56ee317b-4e44-4820-bc00-23debc7b87c1
- Local pid:
-
pubs:1022723
- Source identifiers:
-
1022723
- Deposit date:
-
2019-07-01
Terms of use
- Copyright holder:
- Elsevier
- Copyright date:
- 2019
- Rights statement:
- © 2019 Elsevier Inc. All rights reserved.
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/j.rdc.2019.04.007
If you are the owner of this record, you can report an update to it here: Report update to this record